Jane Street Group, LLC Nuvalent, Inc. Put Options Transaction History

Jane Street Group, LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2025 May 14, 2025	SELL	$67.38 - $88.96 $1.81 Million - $2.39 Million	-26,900 Reduced 80.06%	6,700 $475,000
Q4 2024 Feb 14, 2025	SELL	$77.87 - $104.93 $7.49 Million - $10.1 Million	-96,200 Reduced 74.11%	33,600 $2.63 Million
Q3 2024 Nov 14, 2024	BUY	$67.44 - $112.17 $8.75 Million - $14.6 Million	129,800 New	129,800 $13.3 Million

222

61.1M

334K

199K

Ticker NUVL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,977,800
Market Cap $3.29B
Description
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.